Ventyx Biosciences, Inc.

NasdaqGS:VTYX 株式レポート

時価総額:US$130.8m

Ventyx Biosciences マネジメント

マネジメント 基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Raju Mohan

最高経営責任者

US$9.4m

報酬総額

CEO給与比率6.3%
CEO在任期間6yrs
CEOの所有権2.4%
経営陣の平均在職期間2yrs
取締役会の平均在任期間3.5yrs

経営陣の近況

Recent updates

We Think Ventyx Biosciences (NASDAQ:VTYX) Needs To Drive Business Growth Carefully

Nov 14
We Think Ventyx Biosciences (NASDAQ:VTYX) Needs To Drive Business Growth Carefully

Ventyx Biosciences: Ready To Escape "The Crash Cycle"

Nov 04

Is Ventyx Biosciences (NASDAQ:VTYX) In A Good Position To Invest In Growth?

Jul 12
Is Ventyx Biosciences (NASDAQ:VTYX) In A Good Position To Invest In Growth?

Ventyx Biosciences: Slim Chances In A Fat Market (Rating Downgrade)

Jul 01

Ventyx Pivots To Obesity Amid Transformation

Mar 12

Here's Why We're Watching Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Situation

Feb 15
Here's Why We're Watching Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Situation

Ventyx: Too Risky Right Now After Some Poor Data

Jan 18

Companies Like Ventyx Biosciences (NASDAQ:VTYX) Are In A Position To Invest In Growth

Sep 21
Companies Like Ventyx Biosciences (NASDAQ:VTYX) Are In A Position To Invest In Growth

Ventyx Biosciences (NASDAQ:VTYX) Is In A Good Position To Deliver On Growth Plans

Jun 07
Ventyx Biosciences (NASDAQ:VTYX) Is In A Good Position To Deliver On Growth Plans

We're Not Very Worried About Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Rate

Feb 20
We're Not Very Worried About Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Rate

Ventyx Biosciences: Not Chasing This Rally

Sep 18

We Think Ventyx Biosciences (NASDAQ:VTYX) Can Afford To Drive Business Growth

Aug 19
We Think Ventyx Biosciences (NASDAQ:VTYX) Can Afford To Drive Business Growth

Ventyx Biosciences GAAP EPS of -$0.39 beats by $0.06

Aug 15

Ventyx Biosciences autoimmune/autoinflammatory candidate meets phase 1 goals

Jun 29

We're Not Very Worried About Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Rate

May 06
We're Not Very Worried About Ventyx Biosciences' (NASDAQ:VTYX) Cash Burn Rate

We Think Ventyx Biosciences (NASDAQ:VTYX) Can Afford To Drive Business Growth

Jan 21
We Think Ventyx Biosciences (NASDAQ:VTYX) Can Afford To Drive Business Growth

CEO報酬分析

Ventyx Biosciences の収益と比較して、Raju Mohan の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

-US$153m

Jun 30 2024n/an/a

-US$171m

Mar 31 2024n/an/a

-US$193m

Dec 31 2023US$9mUS$596k

-US$193m

Sep 30 2023n/an/a

-US$181m

Jun 30 2023n/an/a

-US$158m

Mar 31 2023n/an/a

-US$125m

Dec 31 2022US$4mUS$567k

-US$108m

Sep 30 2022n/an/a

-US$91m

Jun 30 2022n/an/a

-US$73m

Mar 31 2022n/an/a

-US$69m

Dec 31 2021US$15mUS$423k

-US$85m

Sep 30 2021n/an/a

-US$84m

Jun 30 2021n/an/a

-US$79m

Mar 31 2021n/an/a

-US$65m

Dec 31 2020US$68kUS$37k

-US$28m

報酬と市場: Rajuの 総報酬 ($USD 9.41M ) は、 US市場 ($USD 647.72K ) の同規模の企業の平均を上回っています。

報酬と収益: Rajuの報酬は増加しましたが、会社は利益を上げていません。


CEO(最高経営責任者

Raju Mohan (66 yo)

6yrs

在職期間

US$9,411,949

報酬

Dr. Raju S. Mohan, Ph.D. founded Ventyx Biosciences, Inc. in November 2018 and serves as its Chief Executive Officer and Director since then and serves as its President since November 22, 2023. Dr. Mohan h...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Sheila Gujrathi
Executive Chairperson3.5yrsUS$486.29k0%
$ 0
Raju Mohan
Founder6yrsUS$9.41m2.37%
$ 3.1m
John Nuss
Chief Scientific Officer5.8yrsUS$3.89m0.37%
$ 490.2k
Roy Gonzales
Interim Principal Financial Officer & Principal Accounting Officerless than a yearデータなし0.0010%
$ 1.4k
Matthew Moore
Chief Operating Officerless than a yearデータなしデータなし
Mark Forman
Chief Medical Officerless than a yearデータなしデータなし

2.0yrs

平均在職期間

56yo

平均年齢

経験豊富な経営陣: VTYXの経営陣は 経験豊富 であると考えられます ( 2年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Sheila Gujrathi
Executive Chairperson3.5yrsUS$486.29k0%
$ 0
Raju Mohan
Founder6yrsUS$9.41m2.37%
$ 3.1m
Allison Hulme
Independent Director1.8yrsUS$834.42k0%
$ 0
Somasundaram Subramaniam
Independent Director6yrsUS$417.35kデータなし
Alexa Kimball
Member of Clinical & Scientific Advisory Boardno dataデータなしデータなし
James Krueger
Member of Clinical & Scientific Advisory Boardno dataデータなしデータなし
Bruce Sands
Member of Clinical & Scientific Advisory Boardno dataデータなしデータなし
Emma Guttman-Yassky
Member of Clinical & Scientific Advisory Boardno dataデータなしデータなし
William White
Independent Director3.5yrsUS$416.29k0%
$ 0
Onaiza Cadoret-Manier
Independent Director1.8yrsUS$837.34k0%
$ 0

3.5yrs

平均在職期間

60.5yo

平均年齢

経験豊富なボード: VTYXの 取締役会経験豊富 であると考えられます ( 3.5年の平均在任期間)。